On the recordJuly 20, 2010
without a statement of policy on rare diseases and orphan products, it is not possible [for the FDA] to ensure consistency in that process.
Source
congress.govEditor's note · Context
Emphasizes the need for FDA policy on rare diseases for consistent treatment processes.
Share & report
More from Bob Casey
Aug 7, 2024
Addressing these challenges is essential to our State's and our country's success, and we are grateful for Senator Casey's work to shine a light on the urgent need to invest in care.
Aug 7, 2024
Thank you to Senator Casey for organizing this hearing and for all you do to improve the support for caregivers.
Aug 7, 2024
These are just a few, Senator Casey of the ways in which what we're hearing here is individual stories ladder up.
Other voices in this conversation
